Renal and patient survival in LCDD. (A) Median renal survival from diagnosis of LCDD was 5.4 years. (B) Renal survival was significantly longer among those who were diagnosed, whereas eGFR was ≥30 mL/min per year compared with those diagnosed once GFR was <30 mL/min per year (P = .004). (C) Renal survival was significantly longer among patients who achieved a hematologic CR/VGPR with first-line chemotherapy compared with those who achieved a hematologic PR/NR (P = .005). (D) Renal survival from ASCT among 11 patients with median GFR of 24 mL/min per year at start of the procedure. (E) Patient survival from commencement of dialysis, censored at the time of transplantation. (F) Patient survival from diagnosis of LCDD; median estimated survival was 14.0 years.